http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016175555-A8

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2df2e1189fa8605916aa5ef7b6df8f95
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-335
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-48
filingDate 2016-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_197bed98b60e27b69b9b80fb9a04741b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f4c39d4e5ae4ba7a45cb3d4a9d9c8097
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1fcee3069072e999973e5e3baefb4185
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef4e0f5b4045eeaf5f761d2eb3853b3d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be57e1340e30606b09ee220a00775e77
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_709d0d2417d9fea533ef4fd60069fce2
publicationDate 2017-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2016175555-A8
titleOfInvention Novel 4-methoxy pyrrole derivatives or salts thereof and pharmaceutical composition comprising the same
abstract The present invention provides a 4-methoxy pyrrole derivative or a pharmaceutically cceptable salt thereof, a preparation method thereof, and a pharmaceutical composition containing the same. The 4-methoxy pyrrole derivatives or pharmaceutically acceptable salts thereof according to the present invention have not only excellent proton pump inhibitory activity, gastric damage-inhibiting activity and defensive factor-enhancing effects, but also excellent eradication activity against H. pylori. Therefore, the 4-methoxy pyrrole derivatives or pharmaceutically acceptable salts thereof can be effectively used for the prevention and treatment of gastrointestinal damage due to gastrointestinal tract ulcer, gastritis, reflux esophagitis or H. pylori . Moreover, the 4-methoxy pyrrole derivatives or pharmaceutically acceptable salts thereof, have inhibitory activities against GPCR and thus can be effectively used for the prevention and treatment of 5-HT receptor-mediated or muscarinic acetylcholine receptor-mediated diseases.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2737470-C1
priorityDate 2015-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID187
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID479
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID17904790
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395454
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID192113
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422088405

Total number of triples: 31.